CME Institute

1.00 CREDIT Alzheimer Disease
0.50 CREDIT Epilepsy
0.50 CREDIT Epilepsy
1.50 CREDIT Depression
0.25 CREDIT Renal Disease
0.50 CREDIT Parkinson Disease
0.25 CREDIT Renal Disease
0.50 CREDIT Depression
0.50 CREDIT Depression
0.25 CREDIT Rett Syndrome

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Generalizability of the Results of Efficacy Trials in First-Episode Schizophrenia: Comparing Outcome and Study Discontinuation of Groups of Participants in the Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial

First-episode schizophrenia patients with suicidal ideation and substance use disorder are often excluded from clinical trials. Omitting...

Read More...